CTC announces new Deputy Director


We are very pleased to announce that Professor Rachael Morton has been officially appointed to the role of Deputy Director of the NHMRC Clinical Trials Centre (CTC).

Rachael brings a wealth of knowledge to the role having worked in Health, Industry, and at the Universities of Oxford and Sydney. Since joining the CTC in 2015, Rachael has established and developed the Health Economics and Health Technology Assessment teams. She has >195 peer-reviewed publications, and with her many collaborators, generated >$70M in research funding. Her research interests include within-trial and economic modelling methods, value of information (VOI) analysis and patient reported outcome measures (PROMs). Rachael is a Board Director for ACTA and co-convenor of the inaugural Health Economists Alongside Trials (HEAT) special interest group. In addition, Rachael is President of the Health Services Research Association of Australia and New Zealand (HSRAANZ), a multidisciplinary organisation that connects researchers, health service managers and policy makers to improve healthcare delivery.

In her role as Deputy Director, Rachael will contribute to oversight of the CTC through the Management Executive Committee and CTC Leadership Forum and deputise for Director Prof Meg Jardine. Rachael will also take on specific responsibility for Academic Career Development at the CTC, reflecting the priority we place on supporting the next generation of academic leaders and developing trials capacity.

Immediate past Deputy Director Professor Tony Keech will continue to develop new initiatives in the Cardiovascular Division, as well as overseeing a well-established program of cardiovascular prevention research. Prof Keech has helped shape the CTC and its achievements in research excellence which have led to improved health outcomes and been recognised in its status as a FMH Flagship Centre.